The incidence of CD44-positive CTCs was significantly associated with tumor location, lymph node metastasis, distant metastasis, and recurrence of GC (P = 0.027, P = 0.033, P = 0.033 and P = 0.011, resp). Here, CD44 is linked to metastatic malignant neoplasm in the lymph nodes.